Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Acetaminophen88 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00271 | 35159219 | Cells | S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent. | 2022 | Details |
A01583 | 34685496 | Cells | Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression. | 2021 | Details |
A02279 | 34439491 | Antioxidants (Basel) | TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species. | 2021 | Details |
A02364 | 34401974 | Cell Biol Toxicol | Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. | 2021 | Details |
A02623 | 34305621 | Front Pharmacol | Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway. | 2021 | Details |
A04090 | 33763324 | Cureus | Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics. | 2021 | Details |
A04767 | 33511336 | JHEP Rep | Sex disparities in waitlisting and liver transplant for acute liver failure. | 2020 | Details |
A04794 | 33504774 | Nat Commun | Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. | 2021 | Details |
A05034 | 33400402 | J Cell Mol Med | Val-Val-Tyr-Pro protects against non-alcoholic steatohepatitis in mice by modulating the gut microbiota and gut-liver axis activation. | 2021 | Details |
A05151 | 33353156 | Int J Mol Sci | Cell Death in Liver Diseases: A Review. | 2020 | Details |
A05555 | 33207858 | Eur J Histochem | The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an <em>in vitro</em> model of benign steatosis. | 2020 | Details |
A05834 | 33103092 | JHEP Rep | Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities. | 2020 | Details |
A05880 | 33090351 | Obes Surg | First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies. | 2020 | Details |
A06533 | 32836224 | Dig Dis | Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease. | 2020 | Details |
A06927 | 32695965 | JHEP Rep | Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD. | 2020 | Details |
A06969 | 32683859 | Anal Chem | High-Selectivity Fluorescent Reporter toward Peroxynitrite in a Coexisting Nonalcoholic Fatty Liver and Drug-Induced Liver Diseases Model. | 2020 | Details |
A07306 | 32546444 | Dig Liver Dis | Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. | 2020 | Details |
A07403 | 32514433 | JGH Open | Epidemiological differences of common liver conditions between Asia and the West. | 2019 | Details |
A08002 | 32283070 | Chem Biol Interact | Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. | 2020 | Details |
A09192 | 31840883 | Phytother Res | Protective effects of glycycoumarin on liver diseases. | 2019 | Details |
A09705 | 31638270 | Clin Pharmacol Ther | Acetaminophen-Induced Liver Damage in Hepatic Steatosis. | 2019 | Details |
A10308 | 31391339 | JCI Insight | The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. | 2019 | Details |
A10514 | 31307592 | Adv Pharmacol | Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. | 2019 | Details |
A11032 | 31076404 | Gut | Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. | 2019 | Details |
A11777 | 30753863 | Eur J Pharmacol | Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway. | 2019 | Details |
A12287 | 30529260 | Food Chem Toxicol | Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects. | 2018 | Details |
A13191 | 30092856 | Gene Expr | Stress of Strains: Inbred Mice in Liver Research. | 2018 | Details |
A13932 | 29682868 | Liver Int | Role and mechanisms of autophagy in acetaminophen-induced liver injury. | 2018 | Details |
A14598 | 29331340 | J Hepatol | Hsp72 protects against liver injury via attenuation of hepatocellular death, oxidative stress, and JNK signaling. | 2018 | Details |
A14906 | 29179698 | BMC Gastroenterol | Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice. | 2017 | Details |
A15830 | 28691103 | J Clin Transl Res | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. | 2017 | Details |
A16026 | 28603092 | Hepatobiliary Pancreat Dis Int | Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance. | 2017 | Details |
A17365 | 27822971 | Expert Opin Drug Metab Toxicol | Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? | 2016 | Details |
A19132 | 26739624 | Toxicol Appl Pharmacol | A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen. | 2015 | Details |
A19609 | 26460177 | Br J Clin Pharmacol | Can paracetamol (acetaminophen) be administered to patients with liver impairment? | 2015 | Details |
A20157 | 26117210 | Vascul Pharmacol | Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome. | 2015 | Details |
A20267 | 26055245 | Nat Rev Gastroenterol Hepatol | Inflammasome activation and function in liver disease. | 2015 | Details |
A20706 | 25788542 | Drug Metab Dispos | Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis. | 2015 | Details |
A21780 | 25048953 | J Hepatol | Cyclophilin inhibition as potential therapy for liver diseases. | 2014 | Details |
A22131 | 24797163 | Sci Rep | Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes. | 2014 | Details |
A22441 | 24575957 | Liver Int | Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. | 2014 | Details |
A22643 | 24388027 | Mayo Clin Proc | Drug-induced liver injury. | 2014 | Details |
A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
A23343 | 23856494 | Food Chem Toxicol | Glutathione defense mechanism in liver injury: insights from animal models. | 2013 | Details |
A23648 | 23598120 | Talanta | Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases. | 2012 | Details |
A24110 | 23223517 | Drug Metab Dispos | Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. | 2012 | Details |
A24164 | 23130907 | Physiol Res | Steatotic rat hepatocytes in primary culture are more susceptible to the acute toxic effect of acetaminophen. | 2012 | Details |
A24343 | 22982943 | Gastroenterology | Sterile inflammation in the liver. | 2012 | Details |
A25611 | 21649732 | J Gastroenterol Hepatol | Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen. | 2012 | Details |
A25982 | 21240014 | J Pediatr Gastroenterol Nutr | Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. | 2011 | Details |
A26158 | 20980222 | Orv Hetil | [Alterations in microRNA expression patterns in liver diseases]. | 2010 | Details |
A27699 | 17640958 | Drug Metab Dispos | Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. | 2007 | Details |
A28338 | 15603755 | Mutat Res | Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. | 2005 | Details |
A28348 | 15554233 | Drug Metab Rev | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 2004 | Details |
A29270 | 34324818 | Biomacromolecules | Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. | 2021 | Details |
A29308 | 34272737 | Med J Aust | Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements. | 2021 | Details |
A30167 | 32875282 | JHEP Rep | Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis. | 2020 | Details |
A31425 | 30595544 | Nucl Med Biol | Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[18F]FCA in mouse models of liver disease. | 2018 | Details |
A31546 | 30309020 | Int J Mol Sci | Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. | 2018 | Details |
A33269 | 26330343 | Am J Physiol Endocrinol Metab | Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions. | 2015 | Details |
A33569 | 25687506 | Cell Mol Life Sci | Pathological implications of cadherin zonation in mouse liver. | 2015 | Details |
A34310 | 23793039 | Food Chem Toxicol | Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis. | 2013 | Details |
A35496 | 20539006 | Am J Physiol Gastrointest Liver Physiol | Diabetic KK-A(y) mice are highly susceptible to oxidative hepatocellular damage induced by acetaminophen. | 2010 | Details |
A36302 | 18501395 | Toxicol Appl Pharmacol | Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate. | 2008 | Details |
A36718 | 17393512 | Hepatology | Chronic intermittent hypoxia predisposes to liver injury. | 2007 | Details |
A38236 | 11812920 | Toxicol Sci | Mechanisms of hepatotoxicity. | 2002 | Details |
A40742 | 6729821 | Toxicol Appl Pharmacol | The toxicity and biotransformation of single doses of acetaminophen in dogs and cats. | 1984 | Details |
A42403 | 34630116 | Front Pharmacol | An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism. | 2021 | Details |
A42750 | 33584986 | World J Hepatol | Autophagy in liver diseases. | 2021 | Details |
A43098 | 32571750 | Clin Res Hepatol Gastroenterol | Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. | 2020 | Details |
A45469 | 24397281 | Liver Int | Panaxatriol saponin ameliorated liver injury by acetaminophen via restoring thioredoxin-1 and pro-caspase-12. | 2014 | Details |
A45806 | 22647274 | J Pharmacol Exp Ther | Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. | 2012 | Details |
A45946 | 21908766 | Toxicol Sci | 3,5,5-trimethyl-hexanoyl-ferrocene diet protects mice from moderate transient acetaminophen-induced hepatotoxicity. | 2011 | Details |
A45953 | 21886053 | South Med J | A paradigm shift in the outpatient approach to liver function tests. | 2011 | Details |
A46419 | 18821593 | Hepatology | Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. | 2008 | Details |
A46471 | 18408456 | Curr Opin Gastroenterol | Drug-induced liver injury in 2007. | 2008 | Details |
A47007 | 30248395 | Alcohol | Pharmacokinetic changes of tramadol in rats with hepatotoxicity induced by ethanol and acetaminophen in perfused rat liver model. | 2018 | Details |
A47333 | 16439473 | Am J Physiol Gastrointest Liver Physiol | Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity. | 2006 | Details |
A47380 | 10397283 | Alcohol Clin Exp Res | Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review. | 1999 | Details |
A47526 | 3518564 | Ann Intern Med | Drug-induced hepatotoxicity. | 1986 | Details |
A47806 | 31545919 | Am J Physiol Gastrointest Liver Physiol | Emerging role of extracellular vesicles in liver diseases. | 2019 | Details |
A48256 | 18335886 | Rev Med Suisse | [Highlights in hepatology]. | 2008 | Details |
A48772 | 29246445 | Biochim Biophys Acta Mol Basis Dis | Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease. | 2017 | Details |
A48828 | 27439970 | Clin Sci (Lond) | NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling. | 2016 | Details |
A48852 | 26609559 | Redox Biol | Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. | 2015 | Details |
A49181 | 15180496 | Curr Drug Metab | Cytochrome P450 and liver diseases. | 2004 | Details |
A50742 | 35282052 | Ann Transl Med | Regulatory mechanism of HIF-1α and its role in liver diseases: a narrative review. | 2022 | Details |
A51972 | 32719086 | Drug Metab Dispos | Multiomics Profiling Reveals Protective Function of Schisandra Lignans against Acetaminophen-Induced Hepatotoxicity. | 2020 | Details |